Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen V Frye

Showing results (71-80 of 126) with videos related to

Pageof 13
Sort By:
Chemmedchem|December 30, 2016
Discovery of Macrocyclic Pyrimidines as MerTK-Specific InhibitorsAndrew L McIver, Weihe Zhang, Qingyang Liu, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 27, 2019
Kinome profiling of non-Hodgkin lymphoma identifies Tyro3 as a therapeutic target in primary effusion lymphomaJason P Wong, Timothy J Stuhlmiller, Louise C Giffin, et al.
Journal of Medicinal Chemistry|October 2, 2023
Discovery of a 53BP1 Small Molecule Antagonist Using a Focused DNA-Encoded Library ScreenDevan J Shell, Caroline A Foley, Qinhong Wang, et al.
Journal of Medicinal Chemistry|April 11, 2025
Discovery of Novel TYRO3/MERTK Dual InhibitorsDeyu Kong, Jichen Zhao, Daowei Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 21, 2016
UNC2025, a MERTK Small-Molecule Inhibitor, Is Therapeutically Effective Alone and in Combination with Methotrexate in Leukemia ModelsDeborah DeRyckere, Alisa B Lee-Sherick, Madeline G Huey, et al.
Journal of Medicinal Chemistry|March 23, 2011
Small-molecule ligands of methyl-lysine binding proteinsJ Martin Herold, Tim J Wigle, Jacqueline L Norris, et al.
Blood|November 15, 2014
Selective inhibition of EZH2 and EZH1 enzymatic activity by a small molecule suppresses MLL-rearranged leukemiaBowen Xu, Doan M On, Anqi Ma, et al.
Journal of Medicinal Chemistry|October 23, 2018
Highly Selective MERTK Inhibitors Achieved by a Single Methyl GroupJichen Zhao, Dehui Zhang, Weihe Zhang, et al.
European Journal of Medicinal Chemistry|April 4, 2025
Exploiting structural variability in the kinase back-pocket to modulate polypharmacology of TAM inhibitorsMegan D Hopkins, Dehui Zhang, Zhilong Chen, et al.
Neuro-Oncology|June 13, 2017
MerTK as a therapeutic target in glioblastomaJing Wu, Lauren N Frady, Ryan E Bash, et al.
Pageof 13

Showing results (71-80 of 126) with videos related to

Sort By:
Pageof 13
Chemmedchem|December 30, 2016
Discovery of Macrocyclic Pyrimidines as MerTK-Specific InhibitorsAndrew L McIver, Weihe Zhang, Qingyang Liu, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 27, 2019
Kinome profiling of non-Hodgkin lymphoma identifies Tyro3 as a therapeutic target in primary effusion lymphomaJason P Wong, Timothy J Stuhlmiller, Louise C Giffin, et al.
Journal of Medicinal Chemistry|October 2, 2023
Discovery of a 53BP1 Small Molecule Antagonist Using a Focused DNA-Encoded Library ScreenDevan J Shell, Caroline A Foley, Qinhong Wang, et al.
Journal of Medicinal Chemistry|April 11, 2025
Discovery of Novel TYRO3/MERTK Dual InhibitorsDeyu Kong, Jichen Zhao, Daowei Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 21, 2016
UNC2025, a MERTK Small-Molecule Inhibitor, Is Therapeutically Effective Alone and in Combination with Methotrexate in Leukemia ModelsDeborah DeRyckere, Alisa B Lee-Sherick, Madeline G Huey, et al.
Journal of Medicinal Chemistry|March 23, 2011
Small-molecule ligands of methyl-lysine binding proteinsJ Martin Herold, Tim J Wigle, Jacqueline L Norris, et al.
Blood|November 15, 2014
Selective inhibition of EZH2 and EZH1 enzymatic activity by a small molecule suppresses MLL-rearranged leukemiaBowen Xu, Doan M On, Anqi Ma, et al.
Journal of Medicinal Chemistry|October 23, 2018
Highly Selective MERTK Inhibitors Achieved by a Single Methyl GroupJichen Zhao, Dehui Zhang, Weihe Zhang, et al.
European Journal of Medicinal Chemistry|April 4, 2025
Exploiting structural variability in the kinase back-pocket to modulate polypharmacology of TAM inhibitorsMegan D Hopkins, Dehui Zhang, Zhilong Chen, et al.
Neuro-Oncology|June 13, 2017
MerTK as a therapeutic target in glioblastomaJing Wu, Lauren N Frady, Ryan E Bash, et al.
Pageof 13